Original language | English (US) |
---|---|
Pages (from-to) | 667-669.e4 |
Journal | Journal of Allergy and Clinical Immunology: In Practice |
Volume | 7 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2019 |
ASJC Scopus subject areas
- Immunology and Allergy
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, No. 2, 02.2019, p. 667-669.e4.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Baked egg oral immunotherapy desensitizes baked egg allergic children to lightly cooked egg
AU - Bird, J. Andrew
AU - Clark, April
AU - Dougherty, Irene
AU - Brown, L. Steven
AU - Arneson, Amy
AU - Crain, Maria
AU - Parrish, Christopher
N1 - Funding Information: The authors of this clinical communication received no financial compensation or incentive for its production. Thermo Fisher Scientific, Phadia, US, Inc., Portage, MI gratuitously performed ImmunoCAP testing. The use of REDCap within this publication is supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) Colorado CTSI Grant Number UL1 RR025780. The contents of the publication are the authors' sole responsibility and do not necessarily represent official NIH views. Funding Information: Conflicts of interest: J. A. Bird reports personal fees from Food Allergy Research and Education, Nutricia North America, Foresite Capital Management, Medscape, and Pharm-Olam International Ltd; grants, personal fees, and other from DBV Technologies; personal fees and nonfinancial support from American College of Allergy, Asthma and Immunology; personal fees and nonfinancial support from Food Allergy Research and Education; grants from Nestle Health Sciences; grants and personal fees from Aimmune Therapeutics, outside the submitted work. A. Clark reports personal fees from Nutricia North America, outside the submitted work. M. Crain reports personal fees from DBV Technologies, outside the submitted work. C. Parrish reports personal fees from Pharmacy Times Continuing Education; nonfinancial support from Aimmune Therapeutics; nonfinancial support from DBV Technologies, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. Clinical Communications
PY - 2019/2
Y1 - 2019/2
UR - http://www.scopus.com/inward/record.url?scp=85054350209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054350209&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2018.07.013
DO - 10.1016/j.jaip.2018.07.013
M3 - Article
C2 - 30053593
AN - SCOPUS:85054350209
SN - 2213-2198
VL - 7
SP - 667-669.e4
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 2
ER -